After finishing at $2.02 in the prior trading day, Gritstone Bio Inc (NASDAQ: GRTS) closed at $2.13, up 5.45%. In other words, the price has increased by $+0.1100 from its previous closing price. On the day, 2343155 shares were traded.
Ratios:
Our goal is to gain a better understanding of GRTS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.88 and its Current Ratio is at 3.88. In the meantime, Its Debt-to-Equity ratio is 1.29 whereas as Long-Term Debt/Eq ratio is at 1.21.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on February 28, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $4.
On March 28, 2023, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $8.B. Riley Securities initiated its Buy rating on March 28, 2023, with a $8 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 23 when Economides Vassiliki bought 12,000 shares for $1.90 per share. The transaction valued at 22,829 led to the insider holds 214,058 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GRTS now has a Market Capitalization of 192.59M and an Enterprise Value of 203.94M. For the stock, the TTM Price-to-Sale (P/S) ratio is 77.21 while its Price-to-Book (P/B) ratio in mrq is 2.68. Its current Enterprise Value per Revenue stands at 77.57 whereas that against EBITDA is -1.59.
Stock Price History:
Over the past 52 weeks, GRTS has reached a high of $3.33, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is 2.3322, while the 200-Day Moving Average is calculated to be 1.9789.
Shares Statistics:
The stock has traded on average 2.02M shares per day over the past 3-months and 1.93M shares per day over the last 10 days, according to various share statistics. A total of 95.34M shares are outstanding, with a floating share count of 86.93M. Insiders hold about 8.82% of the company’s shares, while institutions hold 39.66% stake in the company. Shares short for GRTS as of Feb 15, 2024 were 9.14M with a Short Ratio of 4.52, compared to 9.39M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.59% and a Short% of Float of 10.86%.
Earnings Estimates
Its stock is currently analyzed by 8 different market analysts. On average, analysts expect EPS of -$0.34 for the current quarter, with a high estimate of -$0.29 and a low estimate of -$0.42, while EPS last year was -$0.3. The consensus estimate for the next quarter is -$0.34, with high estimates of -$0.3 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$1.23 and -$1.47 for the fiscal current year, implying an average EPS of -$1.3. EPS for the following year is -$1.08, with 7 analysts recommending between -$0.58 and -$1.49.
Revenue Estimates
A total of 7 analysts have provided revenue estimates for GRTS’s current fiscal year. The highest revenue estimate was $16.64M, while the lowest revenue estimate was $6M, resulting in an average revenue estimate of $9.88M. In the same quarter a year ago, actual revenue was $19.95M, down -50.50% from the average estimate.
